Carborane compound, and method for producing halogenated aromatic compound using the same

The use of a carborane catalyst with sulfur-bonded carbon atoms addresses the challenges of harsh conditions and limited reactivity in halogenation reactions, achieving high yield and selectivity in producing halogenated aromatic compounds with adjustable halogenation.

JP2024165208APending Publication Date: 2024-11-28OSAKA UNIVERSITY
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2023081147
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-16
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Existing methods for producing halogenated aromatic compounds face challenges such as harsh reaction conditions, limited raw material applicability, low reactivity, and difficulty in controlling selectivity and regioselectivity, particularly when using molecular halogen reagents and N-halosuccinimides.

Method used

A carborane compound with a sulfur atom bonded to carbon atoms is used as a catalyst, in combination with a cocatalyst and a halogenating agent, to perform halogenation reactions under mild conditions, allowing for high activity, selectivity, and regioselectivity, and enabling the production of halogenated aromatic compounds with adjustable halogen atom incorporation.

Benefits of technology

The carborane catalyst exhibits high activity and stability, enabling the production of halogenated aromatic compounds with high yield and selectivity under mild conditions, applicable to a wide range of aromatic compounds, and allows for easy adjustment of the number of halogen atoms introduced.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024165208000058
    Figure 2024165208000058
  • Figure 2024165208000059
    Figure 2024165208000059
  • Figure 2024165208000001
    Figure 2024165208000001
Patent Text Reader

Abstract

To provide a catalytic compound that exhibits high activity in halogenation reaction of aromatic compounds, and a method for producing a halogenated aromatic compound using the compound.SOLUTION: The invention provides a carborane compound represented by the general formula (1) in the figure (where R1 and R2 each independently represent a hydrogen atom or a sulfur atom-containing substituent, and at least one of R1 and R2 is a sulfur atom-containing substituent). Preferably, the sulfur atom-containing substituent is an alkylthio group.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a carborane compound and a method for producing a halogenated aromatic compound using the same. [Background technology]

[0002] Aromatic compounds are widely used as various functional organic molecules, such as in pharmaceuticals, agricultural chemicals, light-emitting devices, and electronic materials, and there has always been a demand for the development of technologies that enable precise molecular processing. In particular, the cross-coupling reaction, which won the 2010 Nobel Prize in Chemistry, makes it possible to selectively link aromatic compounds, and has become an indispensable technique in modern academic and industrial research.

[0003] Molecules containing halogen elements such as chlorine (Cl), bromine (Br), and iodine (I) (halogen compounds) are used as raw materials in cross-coupling reactions and are recognized as versatile building blocks that can be transformed into a variety of chemical bonds. In addition to their value as synthetic intermediates, the fact that approximately 60% of commercially available pharmaceuticals and agricultural chemicals are halogenated compounds indicates their importance as a means of adjusting molecular properties.

[0004] Conventionally, in the production methods of halogen compounds, it has been common to use molecular halogen reagents such as Cl2, Br2, and I2 in combination with an acid catalyst as an activator. However, production methods using molecular halogen reagents require harsh reaction conditions, such as the use of acids, which can destroy the delicate molecular structures of pharmaceuticals and fine chemicals, and also make it difficult to control selectivity. In response to this, methods have been proposed, for example, in Patent Documents 1 and 2.

[0005] However, in the method of Patent Document 1, the raw material is limited to aromatic compounds having an amino group, and cannot be used for a wide range of raw material compounds. In addition, in the method of Patent Document 2, although the reaction temperature is mild, the reaction conditions are severe in that a large excess of acid is required relative to the amount of substrate, and there is room for improvement in reactivity. Under these circumstances, a drastic technological innovation was required for the production methods of halogen compounds.

[0006] In addition, as a halogenating agent used in the method for producing a halogen compound, N-halosuccinimide (NCS, NBS, NIS) is an inexpensive and stable crystalline solid, and is widely used as an alternative halogenating reagent with excellent practicality. As a production method using N-halosuccinimide, for example, the method described in Non-Patent Document 1 has been proposed. However, even the production methods using N-halosuccinimides have low reactivity and are not sufficient. As described above, there has been a need to develop an effective catalyst that can be used in the production of halogen compounds. [Prior art documents] [Patent documents]

[0007] [Patent Document 1] Japanese Patent Application Publication No. 55-47633 [Patent Document 2] International Publication No. 2008 / 143141 [Non-patent literature]

[0008] [Non-Patent Document 1] “Triptycenyl Sulfide: A Practical and Active Catalyst for Electrophilic Aromatic Halogenation Using N-Halosuccinimides”, Yuji Nishii, M. Ikeda, Y. Hayashi, S. Kawauchi, M. Miura, J. Am. Chem. Soc. 142, 3, pp.1621-1629 (2020). Summary of the Invention [Problem to be solved by the invention]

[0009] An object of the present invention is to provide a catalyst compound which exhibits high activity in the halogenation reaction of aromatic compounds, and a method for producing halogenated aromatic compounds using the same. [Means for solving the problem]

[0010] As a result of intensive research aimed at solving the above problems, the present inventors have found that halogenated aromatic compounds can be produced in high yields by using m-carborane in which a sulfur atom is directly bonded to at least one of two carbon atoms. Based on this finding, the inventors have carried out further research and have completed the present invention.

[0011] The present invention includes the following inventions. [1] A carborane compound represented by the following general formula (1): [ka] (In the formula, R 1 , and R 2 each independently represents a hydrogen atom or a sulfur atom-containing substituent; R 1 and R 2 At least one of these is a sulfur atom-containing substituent. [2] The carborane compound according to [1], wherein the sulfur atom-containing substituent is an alkylthio group. [3] R 1 , and R 2 is an alkylthio group. [4] The carborane compound according to [1] or [2], wherein the boron atom constituting the carborane compound further has a substituent. [5] The carborane compound according to [4], wherein the substituent is selected from the group consisting of an acyl group, a siloxy group, a silyl group, an alkyl group, and a halogen atom. [6] The carborane compound according to [4], wherein the substituents are not present on the boron atoms at the 2- and 3-positions. [7] A method for producing a halogenated aromatic compound, comprising reacting an aromatic compound having at least one aromatic group, the aromatic group having at least one hydrogen atom, in the presence of the carborane compound according to [1] or [2], a co-catalyst, and a halogenating agent to obtain a halogenated aromatic compound, the aromatic group having a halogen atom. [8] The method for producing a halogenated aromatic compound according to [7], wherein the reaction is carried out in the presence of an aprotic solvent. [9] The method for producing a halogenated aromatic compound according to [7], wherein the co-catalyst is at least one selected from the group consisting of indium(III) trifluoromethanesulfonate, trifluoromethanesulfonic acid, silver trifluoromethanesulfonate, silver(I) tetrafluoroborate, silver(I) hexafluorophosphate, and silver hexafluoroantimonate(V).

[10] The method for producing a halogenated aromatic compound according to [7], wherein the co-catalyst is silver hexafluoroantimonate(V).

[11] The method for producing a halogenated aromatic compound according to [7], wherein the halogenating agent is an N-halogen bond type halogenating agent.

[12] The method for producing a halogenated aromatic compound according to [7], wherein the reaction temperature is within the range of 5 to 100°C.

[13] The method for producing a halogenated aromatic compound according to [7], wherein the halogen atom is selected from the group consisting of a chlorine atom, a bromine atom, and an iodine atom.

[14] Halogenated aromatic compounds represented by the following formulas (3-1) to (3-6): [ka] [ka] [ka] [ka] [ka] or [ka] Effect of the Invention

[0012] According to the present invention, there are provided a catalyst compound which exhibits high activity in the halogenation reaction of an aromatic compound, and a method for producing a halogenated aromatic compound using the same. Furthermore, according to the present invention, it is possible to provide a catalyst compound having high chemical selectivity and regioselectivity in the halogenation reaction of an aromatic compound, and a method for producing a halogenated aromatic compound using the same. Furthermore, according to the present invention, it is possible to provide a catalyst compound that exhibits high activity in the halogenation reaction of an aromatic compound under mild reaction conditions (e.g., a reaction temperature of 100°C or less; a reduced amount of acid used, etc.), and a method for producing a halogenated aromatic compound using the same. Furthermore, the present invention is applicable to a wide range of aromatic compounds having various functional groups, and the corresponding halogenated aromatic compounds can be produced. Furthermore, it has been difficult to adjust the number of halogen atoms introduced into a benzene ring of an aromatic compound. However, according to the present invention, the number of halogen atoms introduced into a benzene ring can be easily adjusted by adjusting the amount of the catalyst or the amount of the halogenating reagent. Furthermore, according to the present invention, since the catalyst compound has excellent stability, the catalyst compound can be recovered after the halogenation reaction and reused. [Brief description of the drawings]

[0013] [Figure 1] 1 is a schematic diagram of a reaction mechanism in a method for producing a halogenated aromatic compound according to the present invention. [Diagram 2] FIG. 1 is a diagram showing the results of Example 3 and Comparative Example 3. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0014] The carborane compound of the present invention has a structure represented by the following general formula (1). [ka] (In the formula, R 1 , and R 2 each independently represents a hydrogen atom or a sulfur atom-containing substituent; R 1 and R 2 At least one of these is a sulfur atom-containing substituent.

[0015] Carborane (dicarbadodecaborane) is a cluster molecule with a regular icosahedral structure consisting of ten boron atoms and two carbon atoms. The m-carborane (1,7-dicarbadodecaborane) compound of the present invention has a structure in which a sulfur atom contained in a sulfur atom-containing substituent is directly bonded to at least one of two carbon atoms.

[0016] In the prior art, there remains a problem that the electronic state of the catalytic active site involved in the reactivity of a catalyst used in the halogenation reaction of an aromatic compound cannot be precisely controlled. The reason for this is that it has been difficult to achieve both of the contradictory properties required of a catalyst: high donor properties for capturing halogen atoms from halogenating reagents and excellent acceptor properties for transferring halogen atoms to the aromatic compound, which is the reaction substrate. In contrast, when the carborane compound of the present invention is used, the substitution position of the sulfur atom-containing substituent can be optimized, and a substituent can be introduced onto the boron atom of the carborane as necessary, thereby enabling precise tuning of the electronic state, thereby achieving both donor property and acceptor property suitable for halogenation reactions. The carborane compound of the present invention has excellent stability as a catalyst, and has a structure in which a sulfur atom contained in a sulfur-containing substituent is directly bonded to at least one of two carbon atoms, thereby enabling wide control of the electronic state involved in the halogenation reaction of an aromatic compound. Specifically, when an m-carborane compound having a sulfur-containing substituent on the carbon atom is mixed with a cocatalyst and a halogenating agent, a highly reactive halosulfonium complex is formed, which undergoes an electrophilic substitution reaction with an aromatic compound to obtain the desired halogenated aromatic compound. A schematic diagram of the assumed reaction mechanism is shown in Figure 1.

[0017] In Fig. 1, a halosulfonium complex, which is a reactive species, is formed by the reaction of N-halosuccinimide, a m-carborane catalyst having a sulfur atom-containing substituent (catalyst A in Example 1-1 in Fig. 1), and a co-catalyst (AgSbF6 in Fig. 1). Here, a halogen atom is transferred from the halogenating agent to the sulfur atom of the carborane catalyst, and the SbF6 anion contained in the co-catalyst serves as a counter anion. The halogen atom in the halosulfonium complex is highly electrophilic and can be electrophilically added to the aromatic substrate to give an arenium ion intermediate, in which the halogen atom is transferred to the aromatic substrate, regenerating the carborane catalyst as shown in the upper part of Figure 1. The halogen-receiving arenium ion intermediate is deprotonated by Ag-succinimide to give the desired halogenated aromatic compound, while producing succinimide as a by-product and regenerating the cocatalyst. In addition, since the m-carborane compound according to the present invention has excellent chemical and thermal stability, it can be recovered and reused after being subjected to the halogenation reaction shown in FIG.

[0018] R 1 , and R 2The sulfur atom-containing substituent in the above formula may be a substituent having a sulfur atom that directly bonds to the carbon atom of m-carborane and a hydrocarbon group. Specific examples include alkylthio groups and arylthio groups, with alkylthio groups being preferred because they exhibit higher activity in the halogenation reaction of aromatic compounds. The alkylthio group may be either linear or branched. The number of carbon atoms in the alkyl group of the alkylthio group is, for example, preferably 1 to 8, and from the viewpoint of exhibiting higher activity in the halogenation reaction of aromatic compounds, more preferably 1 to 6, still more preferably 1 to 4, and particularly preferably 1 to 3. Specific examples of the alkylthio group include a methylthio group, an ethylthio group, an n-propylthio group, an isopropylthio group, and an n-butylthio group. The number of carbon atoms contained in the aryl group of the arylthio group is, for example, preferably 6 to 30, more preferably 6 to 22, still more preferably 6 to 14, and particularly preferably 6 to 10. Specific examples of the arylthio group include a phenylthio group, a toluylthio group, and a naphthylthio group.

[0019] In one preferred embodiment, R 1 , and R 2 is an alkylthio group.

[0020] Another preferred embodiment includes a carborane compound in which the boron atom constituting the carborane compound has a substituent. Another embodiment includes a carborane compound in which the boron atom constituting the carborane compound does not have a substituent.

[0021] In the carborane compound having a substituent on a boron atom, the number of the substituents is preferably 1 to 8, and more preferably 2 to 8.

[0022] Examples of the substituent that the carborane compound has on the boron atom include an acyl group, a siloxy group, a silyl group, an alkyl group, and a halogen atom. Examples of the acyl group include an aliphatic acyl group and an aromatic acyl group. Examples of the aliphatic acyl group include a formyl group, an acetyl group, a propionyl group, a butyryl group, a valeryl group, an isovaleryl group, a pivaloyl group, and a hexanoyl group. The number of carbon atoms in the aliphatic acyl group is preferably 1 to 7, more preferably 1 to 5, and further preferably 1 to 3. Examples of the aromatic acyl group include a benzoyl group, an o-toluoyl group, a m-toluoyl group, a p-toluoyl group, and a phthaloyl group. Examples of the siloxy group include a trimethylsiloxy group, a triethylsiloxy group, an ethyldimethylsiloxy group, a phenyldimethylsiloxy group, a vinyldimethylsiloxy group, and a 3,3,3-trifluoropropyldimethylsiloxy group. Examples of the silyl group include a trialkylsilyl group, an aryl(alkyl)alkoxysilyl group, an alkoxydiarylsilyl group, a triarylsilyl group, an alkyldiarylsilyl group, an aryldialkylsilyl group, and a triarylalkylsilyl group. Examples of the trialkylsilyl group include a trimethylsilyl group, a triethylsilyl group, a triisopropylsilyl group, a dimethylhexylsilyl group, a tert-butyldimethylsilyl group, a methyldiisopropylsilyl group, and an isopropyldimethylsilyl group. The aryl(alkyl)alkoxysilyl group includes, for example, a tert-butylmethoxyphenylsilyl group. An example of the alkoxydiarylsilyl group is a tert-butoxydiphenylsilyl group. An example of the triarylsilyl group is a triphenylsilyl group. An example of the alkyldiarylsilyl group is a tert-butyldiphenylsilyl group. An example of the aryldialkylsilyl group is a dimethylcumenylsilyl group. An example of the triarylsilyl group is a tribenzylsilyl group. The alkyl group may be either linear or branched. The number of carbon atoms in the alkyl group is, for example, preferably 1 to 12, and from the viewpoint of exhibiting higher activity in the halogenation reaction of aromatic compounds, more preferably 1 to 8, further preferably 1 to 6, and particularly preferably 1 to 4. Examples of the alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, a neopentyl group, a 1-ethylpropyl group, a 1,1-dimethylpropyl group, a 1,2-dimethylpropyl group, an n-hexyl group, an n-octyl group, and an isooctyl group. Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.

[0023] Since the carborane compound of the present invention is an m-carborane compound, the positions of the two carbon atoms contained in the carborane skeleton are farther apart than in an o-carborane compound and closer than in a p-carborane compound. It is believed that the two carbon atoms being in this positional relationship, and furthermore, the fact that a sulfur atom is directly bonded to at least one of the two carbon atoms, ensures that the electronic state for forming a halosulfonium complex and the electronic state after its formation are appropriately controlled in the reaction for producing a halogenated aromatic compound.

[0024] Furthermore, the m-carborane compounds having a substituent on the boron atom other than the 2- and 3-positions exhibit higher activity in the halogenation reaction of aromatic compounds, and the halogenation reaction proceeds under milder reaction conditions. The absence of substituents at the 2- and 3-positions allows precise tuning of the electronic state without changing the stereochemical properties around the sulfur atom directly bonded to the carbon atom in the skeleton of the m-carborane compound, which is thought to be important for more efficient reaction of the halosulfonium complex with aromatic compounds.

[0025] The carborane compound having the structure represented by the general formula (1) of the present invention can be produced according to a known method. For example, an o-carborane compound is produced according to the method described in "A New Series of Organoboranes. I. Carboranes from the Reaction of Decaborane with Acetylenic Compounds", TL Heying, JW Ager Jr., SL Clark, DJ Mangold, HL Goldstein, M. Hillman, RJ Polak, and JW Szymanski, Inorganic Chemistry 1963, 2 (6): 1089-1092., heated at a predetermined temperature (e.g., 400 to 700°C), and purified to produce m-carborane (1,7-dicarbadodecaborane), and a sulfur atom-containing substituent can be introduced by a known substituent introduction method (e.g., a method of reacting an organic sulfur compound with m-carborane in the presence of a strong base, etc.). In addition, the m-carborane compound as the raw material that does not have a sulfur atom-containing substituent may be a commercially available product. Furthermore, by using an m-carborane compound that does not have a sulfur atom-containing substituent but has a mercapto group at the 1-position and / or 7-position, a sulfur atom-containing substituent can be introduced by a known method for introducing a substituent. As the m-carborane compound having a mercapto group at the 1-position and / or 7-position, a commercially available product can be used. Furthermore, as a method for introducing a substituent into the boron atom constituting the starting m-carborane compound, a known method (for example, a method using an electrophilic substitution reaction, etc.) can be used.

[0026] In this specification, the upper and lower limits of numerical ranges (the amount of each component used, the content, the blending ratio, the value calculated from each component, each physical property, etc.) can be appropriately combined.

[0027] An embodiment of the present invention includes a method for producing a halogenated aromatic compound, comprising reacting an aromatic compound having at least one aromatic group, the aromatic group having at least one hydrogen atom, in the presence of any of the carborane compounds described above, a co-catalyst, and a halogenating agent to obtain a halogenated aromatic compound, the aromatic group having a halogen atom. The method for producing a halogenated aromatic compound according to the present invention makes it possible to replace hydrogen atoms of a hydrocarbon in a ring of an aromatic group with halogen atoms.

[0028] The halogen atom to be substituted for a hydrogen atom of a hydrocarbon in a ring of an aromatic group by the method for producing a halogenated aromatic compound according to the present invention is preferably at least one atom selected from the group consisting of a chlorine atom, a bromine atom, and an iodine atom.

[0029] The aromatic compound used as the substrate is not particularly limited, and any aromatic compound can be used as long as it has at least one aromatic group, and the aromatic group has at least one hydrogen atom. The aromatic compound used as the substrate may be, for example, an aromatic compound represented by the following general formula (2). [ka] (In formula (2), n is an integer of 1 to 5, and R represents a functional group selected from the group consisting of a linear, branched, or cyclic unsubstituted or substituted organic group, an amino group, an amide group, a nitrile group, a nitro group, a hydroxyl group, a carboxyl group, an acylamino group, a carbamoyl group, and a halogen atom.)

[0030] The organic group associated with R may contain a heteroatom. Examples of heteroatoms include nitrogen atoms, sulfur atoms, oxygen atoms, selenium atoms, tellurium atoms, phosphorus atoms, silicon atoms, and boron atoms. The organic group associated with R may include, for example, an -O- group, an -S- group, an -SO2- group, an -SO- group, a -CO- group, etc. The organic group associated with R may include, for example, an -O- group, form a ring, and may be an epoxy group, etc., or may be a condensed non-aromatic heterocyclic group (such as a heterocyclic group in which a diazepine ring and a thiophene ring are condensed). Furthermore, the organic group related to R may be, for example, an epoxy group substituted with a halogen atom. Examples of the halogen atom associated with R and the halogen atom that the organic group associated with R has as a substituent include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.

[0031] The organic group associated with R includes a hydrocarbon group, a heterocyclic group, and the like. The hydrocarbon group associated with R may be either a saturated hydrocarbon group or an unsaturated hydrocarbon group. Examples of the hydrocarbon group include an alkyl group, a cycloalkyl group, an aryl group, an aralkyl group, an alkenyl group, a cycloalkenyl group, an arylalkenyl group, an alkynyl group, a cycloalkynyl group, and an arylalkynyl group. Examples of the heterocyclic group include 5- to 6-membered monocyclic aromatic heterocyclic groups such as a thienyl group, a furyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a 1,2,4-oxadiazolyl group, a 1,3,4-oxadiazolyl group, a 1,2,4-thiadiazolyl group, a 1,3,4-thiadiazolyl group, a triazolyl group, a tetrazolyl group, a triazinyl group, and an N-2-pyrrolidinone group.

[0032] The number of carbon atoms in the alkyl group related to R is not particularly limited, but is preferably 1 to 20, more preferably 1 to 12, and even more preferably 1 to 6. The alkyl group may be either linear or branched. Examples of the alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an n-hexyl group, an n-heptyl group, and an n-octyl group.

[0033] The number of carbon atoms in the cycloalkyl group for R is not particularly limited, but is preferably 3 to 20, more preferably 4 to 12, and even more preferably 5 to 8. Examples of the cycloalkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and a cyclooctyl group.

[0034] The number of carbon atoms contained in the aryl group related to R is not particularly limited, but is preferably 6 to 40, more preferably 6 to 30, and even more preferably 6 to 14. Examples of the aryl group include a phenyl group, a biphenyl group, an indenyl group, a naphthyl group, an anthryl group, a phenanthryl group, a fluorenyl group, a pyrenyl group, a tolyl group, a xylyl group, a trimethylphenyl group, an ethylphenyl group, an isopropylphenyl group, and a tetramethylphenyl group. The number of carbon atoms in the aralkyl group for R is not particularly limited, but is preferably 7 to 40, more preferably 7 to 30, and even more preferably 7 to 15. Examples of the aralkyl group include a benzyl group, a methylbenzyl group, a phenethyl group, a phenylpropyl group, a naphthylmethyl group, an indenylmethyl group, and a biphenylmethyl group. The number of carbon atoms of the alkenyl group for R is not particularly limited, but is preferably 2 to 20, more preferably 2 to 12, and even more preferably 2 to 6. Examples of the alkenyl group include a vinyl group, a 1-propenyl group, a 2-propenyl group, an isopropenyl group, a 3-butenyl group, a 2-butenyl group, a 1-butenyl group, a 1-methyl-2-propenyl group, a 4-pentenyl group, and a hexenyl group. The number of carbon atoms in the cycloalkyl group for R is not particularly limited, but is preferably 3-30, more preferably 4-28, and even more preferably 5-25. Examples of cycloalkenyl groups include saturated monocyclic hydrocarbon groups such as cyclopropenyl group, cyclobutenyl group, cyclopentenyl group, cyclohexenyl group, oxocyclohexenyl group, cyclohexenylmethyl group, cyclohexenylethyl group, cycloheptenyl group, oxocycloheptenyl group, cycloheptenylmethyl group, and cycloheptenylethyl group; and unsaturated bicyclic hydrocarbon groups such as oxoindenyl group and bicyclo[2.2.1]hept-2-enyl group. The number of carbon atoms contained in the arylalkenyl group for R is not particularly limited, but is preferably 7 to 40, more preferably 7 to 30, and even more preferably 7 to 15. Examples of the arylalkenyl group include a styryl group, a 1-phenylallyl group, a 2-phenylallyl group, a 3-phenylallyl group, a 3,3-diphenylallyl group, a 2,2-diphenylvinyl group, a 1,2-diphenylvinyl group, a 1-phenyl-1-butenyl group, and a 3-phenyl-1-butenyl group. The number of carbon atoms of the alkynyl group for R is not particularly limited, but is preferably 2 to 20, more preferably 2 to 12, and even more preferably 2 to 6. Examples of the alkynyl group include an ethynyl group, an n-propynyl group, an n-butynyl group, an isobutynyl group, an n-pentynyl group, a 1-hexynyl group, a 2-hexynyl group, a 2-heptynyl group, and a 1-octynyl group. The number of carbon atoms contained in the cycloalkynyl group for R is not particularly limited, but is preferably 3 to 30, more preferably 4 to 28, and even more preferably 5 to 25. Examples of the cycloalkynyl group include a cyclobutynyl group, a cyclopentynyl group, a cyclohexynyl group, a cycloheptynyl group, and a cyclooctynyl group. The number of carbon atoms contained in the arylalkynyl group for R is not particularly limited, but is preferably 7 to 40, more preferably 7 to 30, and even more preferably 7 to 15. Examples of the arylalkynyl group include a phenylethynyl group, a tolylethynyl group, a biphenylylethynyl group, and a naphthylethynyl group.

[0035] The hydrocarbon group represented by R may have a substituent. Examples of the substituent include a hydroxyl group, a halogen atom, a nitrile group, an amino group, an azide group, an isothiocyanate group, and an alkyl group having 1 to 6 carbon atoms. Therefore, the hydrocarbon group related to R may be, for example, an alkylamino group, etc. Examples of the alkylamino group include monoalkylamino groups such as methylamino group, ethylamino group, propylamino group, isopropylamino group, butylamino group, sec-butylamino group, and tert-butylamino group, and dialkylamino groups such as dimethylamino group, diethylamino group, ethylmethylamino group, dipropylamino group, methylpropylamino group, and diisopropylamino group. In formula (2), n is an integer of 1 or more and 5 or less, and may be an integer of 2 or more and 5 or less.

[0036] Specific examples of the aromatic compounds represented by the general formula (2) include aromatic compounds having an alkyl group such as toluene, o-xylene, m-xylene, p-xylene, mesitylene, 1,2,3-trimethylbenzene, 1-methylnaphthalene, 2-methylnaphthalene, 1,2-dimethylnaphthalene, ethylbenzene, α-haloethylbenzene, diethylbenzene, propylbenzene, diisopropylbenzene, butylbenzene, isobutylbenzene, s-butylbenzene, cumene, and cymene; diphenylmethane, 1,2-diphenylethane, and the like. Aromatic compounds having an aralkyl group, such as benzene, 2,2-diphenylpropane, and triphenylmethane; aromatic compounds having an aryl group, such as biphenyl, o-terphenyl, m-terphenyl, and p-terphenyl; aromatic compounds having an alkoxy group, such as o-methylanisole, m-methylanisole, p-methylanisole, ethylanisole, phenetole, and methoxyphenol; benzoic acid, o-methylbenzoic acid, m-methylbenzoic acid, p-methylbenzoic acid, ethylbenzoic acid, oxybenzoic acid, aminobenzoic acid, dimethyl Aromatic compounds having a carboxyl group, such as aminobenzoic acid, phthalic acid, isophthalic acid, terephthalic acid, naphthalenecarboxylic acid, naphthalenedicarboxylic acid, furancarboxylic acid, thiophenecarboxylic acid, pyridinecarboxylic acid, and 2-(4-phenyl-3-fluorophenyl)propanoic acid (also known as "flurbiprofen"); aromatic compounds having a halogen atom, such as bromobenzene, chlorobenzene, halotoluenes (p-bromotoluene, p-chlorotoluene, etc.), and haloxylenes; nitrobenzene, p-methylnitrobenzene, p- Examples of aromatic compounds having a nitro group include ethynylnitrobenzene and picric acid; aromatic compounds having a hydroxyl group include phenol, o-cresol, m-cresol, p-cresol, xylenol, 1-hydroxy-4-isopropylphenol, thymol, hydroquinone, resorcinol, pyrogallol, di(4-hydroxyphenyl)methane, 1,2-di(4-hydroxyphenyl)ethane, and 2,2-di(4-hydroxyphenyl)propane; and thienodiazepine compounds such as brotizolam and etiram.

[0037] The aromatic compound used as the substrate may be any aromatic compound in which the aromatic group has at least one hydrogen atom. Examples of the aromatic compound include, in addition to the aromatic compound represented by general formula (2), condensed polycyclic aromatic compounds having a benzene ring as a part thereof represented by general formula (2); aromatic compounds having a hexasubstituted benzene skeleton, the benzene skeleton having one or more aromatic groups each having at least one hydrogen atom (e.g., hexaphenylbenzene and its derivatives, etc.). The aromatic group contained in the aromatic compound having a hexa-substituted benzene skeleton may be an aromatic group represented by general formula (2). The benzene ring represented by general formula (2) and the condensed polycyclic aromatic compound may be bonded directly or via an -O- group, an -S- group, an -SO2- group, an -SO- group, an -CO- group, an ester bond, or the like.

[0038] Examples of the condensed polycyclic aromatic compound include a condensed benzene ring compound whose ring is composed only of a benzene ring; a condensed polycyclic aromatic compound whose ring contains only a benzene ring and carbon atoms; and a condensed aromatic heterocyclic compound containing a hetero ring and a benzene ring. The number of each ring in the condensed polycyclic aromatic compound is not particularly limited, and may be 1 or more, or may be 2 or more. For example, the condensed aromatic heterocyclic compound may have at least one heterocycle and at least one benzene ring, and may be a compound having at least one heterocycle and at least two benzene rings. In these condensed polycyclic aromatic compounds, a compound having a functional group R explained in relation to general formula (2) can be used as the substrate aromatic compound.

[0039] Examples of the condensed benzene ring compound include naphthalene, anthracene, phenanthrene, tetracene, pentacene, benzopyrene, chrysene, pyrene, triphenylene, corannulene, coronene, and ovalene. Examples of the condensed polycyclic aromatic compounds include acenaphthene, fluorene, fluoranthene, and indane.

[0040] Examples of condensed aromatic heterocyclic compounds include indole compounds (indole, tryptophan, indigo, indomethacin, indoline, indolenine, oxindole, indoxyl, isatin, etc.), benzofuran compounds (benzofuran, coumaran-2-one, etc.), benzothiophene compounds (benzothiophene, etc.), benzoazole compounds (benzo-1,2-azoles such as indazole, benzisoxazole, and benzisothiazole; benzimidazole, etc.), , benzoxazole, benzothiazole and other benzo-1,3-azoles, etc.), imidazopyridine compounds (zolpidem, etc.), naphthofuran compounds (naphtho[1,2-b]furan, naphtho[2,1-b]furan, etc.), phthalimide, phthalic anhydride and other aromatic compounds having a hetero five-membered ring and a benzene ring; quinoline compounds (quinoline, isoquinoline, quinolizinium salts, 9aH-quinolizine, 2H-quinolizine, 4H-quinolizine, quinoline N-oxide, 2-quinolone , 4-quinolone, isoquinolone, isoquinoline N-oxide, homophthalic acid imide, etc.), 1-benzopyrylium salts (anthocyanins, anthocyanidins, etc.), 2-benzopyrylium salts, benzopyran compounds (benzopyrans (2H-chromene, 4H-chromene, 1H-isochromene, 3H-isochromene), benzo-2-pyrone (coumarin), benzo-4-pyrone (chromone), flavones, isoflavones, luteolin, and other compounds having a benzopyran skeleton; isochromans, chromans, etc. benzopyran derivatives such as cinnoline, phthalazine, quinazoline, quinoxaline, etc.), naphthopyran compounds (3H-naphtho[2,1-b]pyran, 2H-naphtho[1,2-b]pyran, 2H-naphtho[2,3-b]pyran, 6H-dibenzo[b,d]pyran, 6H-benzo[c]chromen-6-one, etc.), 1-benzothiopyrylium salts, 2-benzothiopyrylium salts, benzodioxane, and other aromatic compounds having a hetero six-membered ring and a benzene ring;Benzazepine compounds (3H-3-benzoazepine, etc.), acridine compounds (acridine, 9-phenylacridine, 9(10H)-acridone, 3-amino-9-(p-aminophenyl)acridine, etc.), phenothiazine compounds (chlorpromazine, levomepromazine, fludecane, perphenazine, etc.), β-carboline compounds (ethyl 9H-pyrido[3,4-b]indole-3-carboxylate, 2,3,4,9-tetrahydro-1H-β-carboline-1-carboxylic acid, etc.), benzodiazepine compounds (clotiazepam, lorazepam, bromazepam, alprazolam, diazepam, cloxazolam, chlordiazepoxide, ethyl loflazepate, triazolam, lormetazepam, nitrazepam, flunitrazepam, estazolam, quazepam, flurazepam, haloxazolam, etc.), benzoxepin compounds (6,11-dihydro-11-oxodibenzo[b,e]oxepin-2-acetic acid, etc.), (also known as "Isoxepac"), 8-methoxy-1-benzoxepin-3,5-dione, etc.), benzodioxepin compounds (3,4-dihydro-2H-1,5-benzodioxepin-7-carboxylic acid, olopatadine (trade name "Allelock") manufactured by Kyowa Kirin Co., Ltd., etc.), dibenzothiepine compounds (10,11-dihydrodibenzo[b,f]thiepine, 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid (also known as "zaltoprofen"), etc.), and other aromatic compounds having a hetero seven-membered ring and a benzene ring;

[0041] A preferred embodiment of the present invention is a method for producing a halogenated aromatic compound, in which a halogenation reaction of a substrate aromatic compound is carried out in the presence of an aprotic solvent.

[0042] Examples of the aprotic solvent include haloalkane solvents, aprotic polar solvents, etc. These may be used alone or in combination of two or more. Examples of haloalkane solvents include 1,2-dichloroethane (DCE), dichloromethane, and chloroform. Examples of aprotic polar solvents include acetonitrile, propionitrile, nitromethane, and nitroethane.

[0043] Examples of the co-catalyst include indium(III) trifluoromethanesulfonate, trifluoromethanesulfonic acid, silver trifluoromethanesulfonate, silver(I) tetrafluoroborate, silver(I) hexafluorophosphate, and silver hexafluoroantimonate(V), and silver hexafluoroantimonate(V) is preferred, because they are easily capable of forming a halosulfonium complex, which is a reactive species. These may be used alone or in combination of two or more. Commercially available co-catalysts may also be used.

[0044] The amount of the co-catalyst used is preferably 0.1 to 5 molar equivalents, more preferably 0.2 to 4 molar equivalents, and even more preferably 0.5 to 2 molar equivalents, relative to 1 mole of the aromatic compound substrate, from the viewpoint of facilitating the formation of a halosulfonium complex, which is a reactive species.

[0045] As the halogenating agent, an N-halogen bond type halogenating agent such as iodine monochloride can be mentioned, since it easily forms a halosulfonium complex, which is a reactive species. Examples of N-halogen bond type halogenating agents include chlorine bond type halogenating agents, bromine bond type halogenating agents, and iodine bond type halogenating agents. N-halogen bond type halogenating agents can be suitably used as halogenating agents because the halogen atom bonded to the nitrogen atom can be easily dissociated in the presence of a co-catalyst. Specific examples of N-halogen bond type halogenating agents include N-halo succinimides, N-halo hydantoins, N-halo phthalimides, N-halosaccharins, and N-halo compounds such as sodium dichloroisocyanurate, dibromoisocyanuric acid, diiodoisocyanuric acid, trichloroisocyanuric acid, tribromoisocyanuric acid, and triiodoisocyanuric acid. Specific examples of N-halosuccinimide include N-chlorosuccinimide (NCS), N-bromosuccinimide (NBS), and N-iodosuccinimide (NIS). Specific examples of N-halohydantoins include 1,3-diiodo-5,5-dimethylhydantoin (DIH), 1,3-dibromo-5,5-dimethylhydantoin (DBH), and 1,3-dichloro-5,5-dimethylhydantoin (DCH). Specific examples of N-halophthalimide include N-chlorophthalimide, N-bromophthalimide, and N-iodophthalimide. Specific examples of N-halosaccharin include N-chlorosaccharin, N-bromosaccharin, and N-iodosaccharin. The halogenating agent may be used alone or in combination of two or more. Commercially available halogenating agents may also be used.

[0046] The amount of the halogenating agent used can be appropriately changed depending on the desired halogenated aromatic compound. In the method for producing a halogenated aromatic compound according to the present invention, the amount of the halogenating agent used can be adjusted to easily carry out a multiple halogenation reaction. In an embodiment, when a halogenated aromatic compound in which a substrate aromatic compound is substituted with one halogen atom is produced, the amount of the halogenating agent used is preferably 0.5 molar equivalents or more and less than 1.5 molar equivalents, more preferably 0.8 molar equivalents or more and 1.4 molar equivalents or less, and even more preferably 0.9 molar equivalents or more and 1.2 molar equivalents or less, relative to 1 mole of the substrate aromatic compound. Within the above range, the halogenation proceeds efficiently, and the chemical selectivity and regioselectivity can be improved.

[0047] In another embodiment, when a halogenated aromatic compound in which a substrate aromatic compound is substituted with two halogen atoms is produced, the amount of the halogenating agent used is preferably 1.5 molar equivalents or more and less than 2.5 molar equivalents, more preferably 1.8 molar equivalents or more and 2.4 molar equivalents or less, and even more preferably 1.9 molar equivalents or more and 2.2 molar equivalents or less, relative to 1 mole of the substrate aromatic compound. Within the above range, the halogenation proceeds efficiently, and the chemical selectivity and regioselectivity can be improved.

[0048] In another embodiment, when a halogenated aromatic compound in which a substrate aromatic compound is substituted with three halogen atoms is produced, the amount of the halogenating agent used is preferably 2.5 molar equivalents or more and less than 3.5 molar equivalents, more preferably 2.8 molar equivalents or more and 3.4 molar equivalents or less, and even more preferably 2.9 molar equivalents or more and 3.2 molar equivalents or less, relative to 1 mole of the substrate aromatic compound. Within the above range, the halogenation proceeds efficiently, and the chemical selectivity and regioselectivity can be improved.

[0049] In another embodiment, when a halogenated aromatic compound in which a substrate aromatic compound is substituted with four halogen atoms is produced, the amount of the halogenating agent used is preferably 3.5 molar equivalents or more and less than 4.5 molar equivalents, more preferably 3.8 molar equivalents or more and 4.4 molar equivalents or less, and even more preferably 3.9 molar equivalents or more and 4.2 molar equivalents or less, relative to 1 mole of the substrate aromatic compound. Within the above range, the halogenation proceeds efficiently, and the chemical selectivity and regioselectivity can be improved.

[0050] By carrying out a multiple halogenation reaction, for example, a polycyclic aromatic compound having multiple halogen atoms, including a case where the substrate aromatic compound has halogen atoms, can be converted relatively easily into a compound having a complex nanocarbon structure by a stepwise cross-coupling reaction.

[0051] In the method for producing a halogenated aromatic compound according to the present invention, the reaction temperature in the presence of a carborane compound, a cocatalyst, and a halogenating agent is preferably within the range of 5 to 100°C, more preferably within the range of 8 to 90°C, and even more preferably within the range of 10 to 80°C. According to the method for producing a halogenated aromatic compound of the present invention, the target compound, that is, a halogenated aromatic compound, can be produced in high yield under mild conditions within the above-mentioned temperature range. Furthermore, in the method for producing a halogenated aromatic compound according to the present invention, no particular pressure application is required, and the target halogenated aromatic compound can be produced under mild conditions such as standard atmospheric pressure (1 atm).

[0052] In the method for producing a halogenated aromatic compound according to the present invention, examples of the halogen atom to be substituted for the hydrogen atom in the aromatic group of the substrate aromatic compound include a chlorine atom, a bromine atom, and an iodine atom.

[0053] Other embodiments of the present invention include halogenated aromatic compounds represented by the following formulas (3-1) to (3-6). [ka]

[0054] [ka]

[0055] [ka]

[0056] [ka]

[0057] [ka] or

[0058] [ka]

[0059] Regarding the halogenated aromatic compounds represented by the above formulas, for example, the halogenated aromatic compounds represented by formulas (3-1) to (3-3) are useful as derivatives of 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropionic acid (also known as "ciprofibrate"). Ciprofibrate (trade name "Modalim (registered trademark)", manufactured by Sanofi-Aventis K.K.) functions as a peroxidase proliferator-activated receptor (PPAR) agonist (e.g., JP 2019-116498 A, WO 2018 / 016596, JP 2000-515526 A, etc.), is known as a lipid-lowering drug, and is useful for pharmaceutical applications. Since ciprofibrate is useful as a lipid-lowering drug, the halogenated aromatic compounds represented by formulas (3-1) to (3-3) are also useful in that they can be used as derivatives of ciprofibrate.

[0060] Moreover, the halogenated aromatic compounds represented by the formulas (3-4) to (3-6) are useful as derivatives of isoxepac, zaltoprofen, and flurbiprofen, respectively. Isoxepac, zaltoprofen, and flurbiprofen, and nimesulide are known as non-steroidal anti-inflammatory drugs (NSAIDs) and are useful in pharmaceutical applications. Isoxepac functions as a COX inhibitor that reversibly inhibits both cyclooxygenase-1 (COX-1) and COX-2 and is useful as a nonsteroidal anti-inflammatory drug, so the halogenated aromatic compounds represented by formula (3-4) are also useful in that they can be used as derivatives of Isoxepac. Since zaltoprofen functions as a COX inhibitor that inhibits COX-2 relatively selectively and is useful as a nonsteroidal anti-inflammatory drug, the halogenated aromatic compound represented by formula (3-5) is also useful in that it can be used as a derivative of zaltoprofen. Flurbiprofen functions as a COX inhibitor that inhibits both COX-1 and COX-2 and is useful as a nonsteroidal anti-inflammatory drug, so the halogenated aromatic compound represented by formula (3-6) is also useful in that it can be used as a flurbiprofen derivative. Without being limited to the above compounds, the halogenated aromatic compounds produced by the present invention are useful in that they can be used as derivatives of active ingredients of agricultural chemicals and pharmaceuticals (for example, other active ingredients such as leflunomide (antirheumatic drug), fenofibrate (hyperlipidemic drug), and statin compounds (HMG-CoA reductase inhibitors)).

[0061] In addition, the halogenated aromatic compound produced by the present invention is not limited to pharmaceuticals, and may be used, for example, as a light-emitting material for an organic EL device (e.g., α-NPD (N,N'-bis(naphthalen-1-yl)-N,N'-bis(phenyl)benzidine), TPD (N,N'-bis(3-methylphenyl)-N,N'-bis(phenyl)benzidine), Alq3 (tris(8-quinolinolato)aluminum), CuPc (copper phthalocyanine), BAlq (Bis(2-methyl-8-quinolinolato)-4-(phenylphenolato)aluminum), DPVBi (4,4'-bis(2,2-diphenylvinyl)biphenyl), spiro-DPVBi, DCM ((E)-2-(2-(4-(dimethylamino)styryl)-6-methyl-4H-pyran-4-ylidene)malononitrile), benzoxazole Zn complex, benzoquinolinol Be complex, etc.), and can also be used as derivatives of electronic component materials. In the production method according to the present invention, as long as an aromatic group has at least one hydrogen atom, the hydrogen atom can be regioselectively substituted with a halogen atom, and therefore, halogenated aromatic compounds can be produced as derivatives of the various components described above.

[0062] The present invention includes embodiments in which all or part of the above-described configurations are combined in various ways within the scope of the technical idea of ​​the present invention, as long as the effects of the present invention are achieved. EXAMPLES

[0063] Next, the present invention will be described in more detail with reference to examples. However, the present invention is not limited to these examples, and many modifications within the scope of the technical concept of the present invention are possible by those having ordinary skill in the art.

[0064] [Example 1: Production Example of m-Carborane Compound] <Examples 1-1 and 1-2> m-Carborane (144 mg, 1.0 mmol) was placed in a two-necked round bottom flask equipped with a N2 balloon and rubber septum. Diethyl ether (4 mL) was then added to the flask via syringe. The resulting solution was cooled to 0°C and n-butyllithium (1.58 M in hexanes, 1.02 mmol) was added dropwise and stirred at 0°C for an additional hour after the addition was complete. Dimethyl disulfide (94 mg, 1.02 mmol) was then added via syringe. The mixture was allowed to warm to room temperature over 30 min, and the resulting solution was poured into water and extracted three times with ethyl acetate. The combined organic layers were dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by silica gel chromatography (eluent: hexane) to give catalyst A (white solid, 50 mg, 26% yield) and catalyst B (white solid, 74 mg, 63% yield).

[0065] Catalyst A: melting point 58.7-59.5 °C; 1 H NMR (400 MHz, CDCl3) δ 2.98 (s, 1H), 2.28 (s, 3H), 3.70-1.40 (cage BH); 13C NMR (100 MHz, CDCl3) δ 74.9, 55.4, 19.3; 11 B NMR (128 MHz, CDCl3) δ -3.6 (d, J = 163.2 Hz, 1B), -9.1~-15.3 (m, 9B); HRMS (EI) m / z: [M] + Calcd for C3H 14 S 10 B2 11 B8190.1819; Found 190.1818.

[0066] Catalyst B: melting point 44.3-45.4 °C; 1 H NMR (400 MHz, CDCl3) δ 2.28 (s, 6H), 3.70-1.40 (cage BH); 13 C NMR (100 MHz, CDCl3) δ 72.9, 19.4; 11 B NMR (128 MHz, CDCl3) δ -6.5 (d, J = 165.5 Hz, 2B), -9.7~-13.1 (m, 8B); HRMS (EI) m / z: [M] + Calcd for C4H 16 S2 10 B2 11 B8236.1697; Found 236.1694. In this manner, catalysts A and B shown in Table 1 were produced.

[0067] <Example 1-3> Catalyst C shown in Table 1 was produced in the same manner as in Example 1-1, except that m-carborane was changed to 9,10-dichloro-m-carborane (0.5 mmol). (White solid: 41 mg, 54% yield) 9,10-Dichloro-m-carborane was prepared by the method described in the literature ("Electrophilic Halogenation of closo-1,2-C2B8H 10 ”, Inorg. Chem. 56, 5971-5975 (2017)). Catalyst C had chlorine atoms on the 9th and 10th boron atoms of m-carborane. Catalyst C: melting point 101.1-102.6 °C; 1 H NMR (400 MHz, CDCl3) δ 2.30 (s, 6H), 3.70-1.40 (cage BH); 13 C NMR (100 MHz, CDCl3) δ 67.5, 19.6; 11 B NMR (128 MHz, CDCl3) δ -0.0 (s, 2B), -6.6 (d, J = 163.8 Hz, 2B), -11.8 (d, J = 169.7 Hz, 4B), -18.8 (d, J = 189.8 Hz, 2B); HRMS (EI) m / z: [M] + Calcd for C4H 14 35 Cl2S2 10 B 11 B9305.0881; Found 305.0894. In this manner, catalyst C shown in Table 1 was produced.

[0068] <Example 1-4> Catalyst D shown in Table 1 was produced in the same manner as in Example 1-1, except that m-carborane was replaced with 9,10-dimethyl-m-carborane (0.43 mmol). (Colorless liquid 63 mg, 56% yield) 9,10-dimethyl-m-carborane was produced by a method described in the literature (A. Himmelspach, M. Finze, Eur. J. Inorg. Chem. 2010, 2012-2024 (2010). K. Ohta, T. Ogawa, A. Kaise, Y. Endo, Bioorg. Med. Chem. 22, 3508-3514 (2014)). Catalyst D: 1 H NMR (400 MHz, CDCl3) δ 2.25 (s, 6H), 0.30 (s, 6H), 3.70-1.40 (cage BH); 13 C NMR (100 MHz, CDCl3) δ 69.9, 19.3, BCH3peaks were not observed; 11B NMR (128 MHz, CDCl3) δ -0.5 (s, 2B), -5.2 (d, J = 160.2 Hz, 2B), -10.4 (d, J = 165.0 Hz, 4B), -16.6 (d, J = 183.0 Hz, 2B); HRMS (EI) m / z: [M] + Calcd for C6H 20 S2 10 B2 11 B8264.2010; Found 264.2014. In this manner, catalyst D shown in Table 1 was produced.

[0069] <Example 1-5> Catalyst E shown in Table 1 was produced in the same manner as in Example 1-1, except that m-carborane was changed to 9,10-bis(trimethylsilylmethyl)-m-carborane (0.5 mmol). (Colorless liquid, 77 mg, 38% yield) Catalyst E: 1 H NMR (400 MHz, CDCl3) δ 2.24 (s, 6H), 0.06 (s, 18H), -0.01 (s, 4H), 3.70-1.40 (cage BH); 13 C NMR (100 MHz, CDCl3) δ 68.9, 18.8, -0.0, BCH2peaks were not observed; 11 B NMR (128 MHz, CDCl3) δ 0.5 (s, 2B), -5.3 (d, J = 156.8 Hz, 2B), -11.2 (d, J = 161.3 Hz, 4B), -16.8 (d, J = 182.6 Hz, 2B); HRMS (EI) m / z: [M-Me] + Calcd for C 11 H 33 S2Si2 10 B 11 B9394.2529; Found 394.2535.

[0070] 9,10-Bis(trimethylsilylmethyl)-m-carborane was prepared in the following manner. A two-necked round-bottom flask equipped with a N2 balloon and rubber septum was charged with 9,10-diiodo-m-carborane (198 mg, 0.5 mmol) and dimethoxyethane (5 mL) was added via syringe. The resulting solution was cooled to 0°C, and trimethylsilylmagnesium bromide (1.0M in diethyl ether, 3.0mmol) was added dropwise. Then, bis(triphenylphosphine)palladium(II) dichloride (35.0mg, 0.05mmol) and copper(I) iodide (9.5mg, 0.05mmol) were added, and the mixture was stirred at 90°C for 16 hours. The resulting solution was poured into an aqueous solution of ammonium chloride and extracted three times with diethyl ether. The combined organic layers were dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by silica gel chromatography (eluent: hexane) to give 9,10-bis(trimethylsilylmethyl)-m-carborane (colorless liquid, 156mg, 99% yield). In this manner, catalyst E shown in Table 1 was produced.

[0071] <Examples 1-6> Catalyst F shown in Table 1 was produced in the same manner as in Example 1-1, except that m-carborane was replaced with 4,5,6,8,9,10,11,12-octamethyl-m-carborane (3.0 mmol) (white solid, 636 mg, 61% yield). 4,5,6,8,9,10,11,12-octamethyl-m-carborane was produced by a method described in the literature (A. Herzog, A. Maderna, GN Harakas, CB Knobler, MF Hawthorne, Chem. Eur. J. 5, 1212-1217 (1999).). Catalyst F had methyl groups on boron atoms other than those at the 2nd and 3rd positions of m-carborane, and had methylthio groups at the 1st and 7th positions. Catalyst F: Sublimation point 280℃; 1 H NMR (400 MHz, CDCl3) δ 2.23 (s, 6H), 0.19 (s, 12H), -0.14 (s, 6H), -0.17 (s, 6H), 3.70-1.40 (cage BH); 13C NMR (100 MHz, CDCl3) δ 66.2, 17.8, -4.0 (BCH3peaks); 11 B NMR (128 MHz, CDCl3) δ 1.6 (s, 2B), -3.0 (s, 2B), -5.5 (s, 4B), -16.9 (d, J = 174.8 Hz, 2B); HRMS (EI) m / z: [M] + Calcd for C 12 H 32 S2 10 B2 11 B8348.2949; Found 348.2953. In this manner, catalyst F shown in Table 1 was produced.

[0072] [Table 1] In the table, ● represents a carbon atom, ◯ represents a boron atom, Me represents a methyl group, and TMS represents a trimethylsilyl group.

[0073] [Comparative Example 1: Production Example of a Catalyst Compound Other than the Present Invention] <Comparative Example 1-1> As a commercially available product, 9-methylthiotriptycene (Trip-SMe) represented by the following formula was used. [ka]

[0074] <Comparative Example 1-2> 9-Methylthio-m-carborane was prepared according to the method described in the literature ("Modular triazine-based carborane-containing carboxylic acids - synthesis and characterisation of potential boron neutron capture therapy agents made of readily accessible building blocks", M. Kellert, DJ Worm, P. Hoppenz, et al. Dalton Trans. 48, 10834-10844 (2019).). In the diagram below, ● represents a carbon atom, ◯ represents a boron atom, and SMe represents a methylthio group. [ka]

[0075] <Comparative Example 1-3> 1-Methylthio-o-carborane was prepared as described in the literature (SV Timofeev, MV Zakharova, EM Mosolova, IA Godovikov, IV Ananyev, IB Sivaev, VI Bregadze, J. Organomet. Chem. 721-722, 92-96 (2012).). In the diagram below, ● represents a carbon atom, ◯ represents a boron atom, and SMe represents a methylthio group. [ka]

[0076] [Example 2] <Example 2-1> In the presence of Catalyst A of Example 1-1, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and 2,4-dichloroanisole was brominated. Specifically, the ratio of the substrate, catalyst A, cocatalyst, and NBS was such that 1 mole of the substrate 2,4-dichloroanisole was reacted with 0.02 molar equivalent of catalyst A, 0.01 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS in terms of sulfur atom at room temperature for 2 hours under atmospheric pressure (1 atm) to produce 2,4-dichloro-6-bromoanisole (yield 60%). [ka]

[0077] <Example 2-2> 2,4-Dichloro-6-bromoanisole was produced (yield 84%) in the same manner as in Example 2-1, except that the catalyst A was changed to the catalyst B in Example 1-2.

[0078] <Example 2-3> 2,4-Dichloro-6-bromoanisole was produced (yield 47%) in the same manner as in Example 2-1, except that the catalyst A was changed to the catalyst C in Example 1-3 and the cocatalyst was changed to trifluoromethanesulfonic acid (0.1 molar equivalent).

[0079] <Example 2-4> 2,4-Dichloro-6-bromoanisole was produced (yield 95%) in the same manner as in Example 2-1, except that the catalyst A was changed to the catalyst D in Example 1-4.

[0080] <Example 2-5> 2,4-Dichloro-6-bromoanisole was produced (yield 91%) in the same manner as in Example 2-1, except that the catalyst A was changed to the catalyst E in Example 1-5 and the reaction time was changed to 1 hour.

[0081] <Example 2-6> 2,4-Dichloro-6-bromoanisole was produced (yield 95%) in the same manner as in Example 2-1, except that the catalyst A was changed to the catalyst F in Example 1-6 and the reaction time was changed to 1 hour.

[0082] [Comparative Example 2] <Comparative Example 2-1> The reaction was carried out in the same manner as in Example 2-1, except that no catalyst was used. However, in the absence of a catalyst, the reaction did not proceed sufficiently, and 2,4-dichloro-6-bromoanisole could not be detected.

[0083] <Comparative Example 2-2> 2,4-Dichloro-6-bromoanisole was produced (yield 3%) in the same manner as in Example 2-1, except that the catalyst A was changed to the catalyst Trip-SMe of Comparative Example 1-1.

[0084] <Comparative Example 2-3> A reaction for producing 2,4-dichloro-6-bromoanisole was carried out in the same manner as in Example 2-1, except that the catalyst A was changed to the catalyst of Comparative Example 1-2 (the formation of the target product was not confirmed in various analyses).

[0085] <Comparative Example 2-4> A reaction for producing 2,4-dichloro-6-bromoanisole was carried out in the same manner as in Example 2-1, except that the catalyst A was changed to the catalyst of Comparative Example 1-3 (the formation of the target product was not confirmed in various analyses).

[0086] [Example 3] <Example 3-1a> In the presence of Catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and phenyl acrylate was brominated. Specifically, 1 mole of the substrate phenyl acrylate was reacted in the presence of 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS at atmospheric pressure (1 atm) and room temperature for 18 hours to produce 3-(4-bromophenyl)acrylic acid (yield 40%). The halogenation was carried out using [ka]

[0087] <Example 3-1b> Except for changing the reaction temperature to 60° C., the same procedure as in Example 3-1a was followed to produce 3-(4-bromophenyl)acrylic acid (yield 81%).

[0088] [Comparative Example 3] <Comparative Examples 3-1 to 3-6> 3-(4-Bromophenyl)acrylic acid was produced in the same manner as in Example 3-1a, except that catalyst F was changed to a catalyst produced in the literature listed in Table 2 below. The results are shown in Figure 2. [Table 2] In Comparative Examples 3-1a (room temperature) and 3-1b (60° C.), 3-(4-bromophenyl)acrylic acid was produced in the same manner as in Examples 3-1a and 3-1b, except that AuCl3 was used as the catalyst instead of Catalyst F. In Comparative Examples 3-2a (room temperature) and 3-2b (60° C.), 3-(4-bromophenyl)acrylic acid was produced in the same manner as in Examples 3-1a and 3-1b, except that FeCl3 was used as the catalyst instead of Catalyst F. In Comparative Examples 3-3a (room temperature) and 3-3b (60°C), 3-nitrobenzenesulfonamide (m-NBSA) and 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) were used as catalysts instead of catalyst F. In the same manner as in Examples 3-1a and 3-1b, 3-(4-bromophenyl)acrylic acid was produced. In Comparative Examples 3-4a (room temperature) and 3-4b (60°C), 3-(4-bromophenyl)acrylic acid was produced in the same manner as in Examples 3-1a and 3-1b, except that dimethylsulfoxide (DMSO) was used as a catalyst instead of catalyst F. In Comparative Examples 3-5a (room temperature) and 3-5b (60° C.), 3-(4-bromophenyl)acrylic acid was produced using [TEMPO][OTf] as a catalyst. In Comparative Examples 3-6a (room temperature) and 3-6b (60°C), 3-(4-bromophenyl)acrylic acid was produced in the same manner as in Examples 3-1a and 3-1b, except that no catalyst was used and trifluoromethanesulfonic acid was used as a co-catalyst instead of AgSbF6.

[0089] From the results shown in FIG. 2, under the reaction conditions using the conventionally known catalysts, the target product was obtained only in low yield, and the recovery rate of the raw material was low, suggesting the occurrence of competing side reactions. In contrast, in Example 3-1b, the target product was obtained in 84% yield. In particular, in Example 3-1b, it was confirmed that the raw material compound was converted to the target compound at almost 100%.

[0090] [Example 4] <Example 4-1> In the presence of catalyst F of Example 1-6, AgSbF6 promoter, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and 2-(2-methoxyethoxy)ethyl 4-methylbenzoate was halogenated. Specifically, 1 mole of the substrate 2-(2-methoxyethoxyethyl)ethyl 4-methylbenzoate was reacted in the presence of 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.2 molar equivalent of NBS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and 60°C for 18 hours to produce the compound represented by the following formula (yield 76%). [ka] 1H NMR (400 MHz, CDCl3) δ 8.20 (d, J= 1.7 Hz, 1H), 7.87 (dd, J = 1.7, 7.8 Hz, 1H), 7.28 (d, J = 8.1 Hz, 1H), 4.48-4.45 (m, 2H), 3.83-3.81 (m, 2H), 3.70-3.67 (m, 2H), 3.57-3.55 (m, 2H), 3.38 (s, 3H), 2.44 (s, 3H); 13 C NMR (100 MHz, CDCl3) δ 165.3, 143.4, 133.5, 130.7, 129.4, 128.5, 124.8, 71.9, 70.6, 69.2, 64.3, 59.1, 23.2.

[0091] <Example 4-2> In the presence of catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and methyl 4-(3-azidopropoxy)benzoate was halogenated. Specifically, 1 mole of the substrate methyl 4-(3-azidopropoxy)benzoate was reacted in the presence of 0.02 molar equivalents of catalyst F, 0.04 molar equivalents of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and 60°C for 18 hours to produce the compound represented by the following formula (yield 80%). [ka] 1 H NMR (400 MHz, CDCl3) δ 8.24 (d, J= 2.1 Hz, 1H), 7.97 (dd, J = 2.1, 8.6 Hz, 1H), 6.91 (d, J = 8.6 Hz, 1H), 4.18 (t, J = 5.9 Hz, 2H), 3.90 (s, 3H), 3.61 (t, J = 6.6 Hz, 2H), 2.16-2.09 (m, 2H);13 C NMR (100 MHz, CDCl3) δ 165.7, 158.5, 134.9, 130.6, 124.0, 111.9, 65.7, 52.2, 48.0, 28.6 (one peak overlapped).

[0092] <Example 4-3> In the presence of catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and 2-phenylisoindoline-1,3-dione was halogenated. Specifically, 1 mole of the substrate 2-phenylisoindoline-1,3-dione was reacted in the presence of 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS in 1,2-dichloroethane solvent (substrate concentration 0.25 M) at atmospheric pressure (1 atm) and room temperature for 14 hours to produce the compound represented by the following formula (yield 97%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.95-7.92 (m, 2H), 7.83-7.74 (m, 2H), 7.65-7.57 (m, 2H), 7.37-7.31 (m, 2H); 13 C NMR (100 MHz, CDCl3) δ 166.8, 134.5, 132.2, 131.5, 130.7, 127.9, 123.8, 121.7.

[0093] <Example 4-4> In the presence of catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and 2-(phenylthio)isoindoline-1,3-dione was halogenated. Specifically, 1 mole of the substrate 2-(phenylthio)isoindoline-1,3-dione was reacted in the presence of 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS in 1,2-dichloroethane solvent (substrate concentration 0.25 M) at atmospheric pressure (1 atm) and room temperature for 14 hours to produce the compound represented by the following formula (yield 97%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.95-7.92 (m, 2H), 7.81-7.78 (m, 2H), 7.51-7.44 (m, 4H); 13 C NMR δ 167.6, 134.9, 134.0, 132.8, 132.5, 131.9, 124.2, 124.0.

[0094] <Example 4-5> In the presence of catalyst F of Example 1-6, AgSbF6 promoter, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and ethyl 4-(ethyl(phenyl)amino)but-2-ynoate was halogenated. Specifically, 1 mole of the substrate ethyl 4-(ethyl(phenyl)amino)but-2-ynoate was reacted in the presence of 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS in 1,2-dichloroethane solvent (substrate concentration 0.25 M) at atmospheric pressure (1 atm) and room temperature for 14 hours to produce the compound represented by the following formula (yield 84%). [ka] 1H NMR (400 MHz, CDCl3) δ 7.33 (d, J= 9.1 Hz, 2H), 6.67 (d, J = 9.1 Hz, 2H), 4.12 (s, 2H), 3.74 (s, 3H), 3.41 (q, J = 7.1 Hz, 2H), 1.21 (t, J = 7.1 Hz, 3H); 13 C NMR (100 MHz, CDCl3) δ 153.6, 146.4, 132.0. 115.5, 110.2, 84.1, 75.5, 52.8, 46.0, 39.9, 12.3.

[0095] <Example 4-6> In the presence of catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and 4-methoxyphenyl 4-hydroxybut-2-ynoate was halogenated. Specifically, 1 mole of the substrate 4-methoxyphenyl 4-hydroxybut-2-ynoate was reacted in the presence of 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS in 1,2-dichloroethane solvent (substrate concentration 0.25 M) at atmospheric pressure (1 atm) and room temperature for 14 hours to produce the compound represented by the following formula (yield 87%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.35 (d, J= 2.8 Hz, 1H), 7.06 (dd, J = 2.8, 8.9 Hz, 1H), 6.87 (d, J = 9.0 Hz, 1H), 4.47-4.40 (m, 2H), 3.86 (s, 3H), 2.83 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 154.2, 151.6, 143.0, 126.1, 121.0, 111.8, 111.5, 88.3, ​​56.5, 50.5 (one peak overlapped).

[0096] <Example 4-7> In the presence of catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and 2-(4-methoxybenzoyl)-5-(triisopropylsilyl)pent-1-en-4-yn-3-one was halogenated. Specifically, 1 mole of the substrate 2-(4-methoxybenzoyl)-5-(triisopropylsilyl)pent-1-en-4-yn-3-one was reacted in the presence of 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS in 1,2-dichloroethane solvent (substrate concentration 0.25 M) at atmospheric pressure (1 atm) and room temperature for 14 hours to produce the compound represented by the following formula (yield 89%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.36 (d, J= 2.2 Hz, 1H), 7.09 (dd, J = 2.2, 8.4 Hz, 1H), 6.82 (d, J = 8.4 Hz, 1H), 6.64 (s, 1H), 5.90-5.84 (m, 1H), 3.86 (s, 3H), 3.54 (s, 2H), 1.15-1.07 (m, 21H); 13C NMR (100 MHz, CDCl3) δ 178.6, 154.4, 148.6, 133.8, 131.9, 131.7, 129.2, 111.9, 111.5, 102.1, 96.4, 56.2, 34.4 18.4, 11.0; (APCI) m / z: [M+H] + Calcd for C 22 H 32 BrO2Si 435.1349; Found 435.1351.

[0097] [Example 5] <Example 5-1> In the presence of catalyst F of Example 1-6, AgSbF6 promoter, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and ciprofibrate was halogenated. Specifically, 1 mole of the substrate ciprofibrate was reacted with 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS in 1,2-dichloroethane solvent (substrate concentration 0.2 M) at atmospheric pressure (1 atm) and room temperature for 18 hours to produce the compound represented by the following formula (yield 90%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.46 (d, J= 2.1 Hz, 1H), 7.12 (dd, J = 2.1, 8.4 Hz, 1H), 7.01 (d, J = 8.4 Hz, 1H), 6.69 (very broad, 1H), 2.83 (dd, J = 8.3, 10.6 Hz, 1H), 1.99 (dd, J = 7.5, 10.6 Hz, 1H), 1.79 (dd, J = 7.6, 8.2 Hz, 1H), 1.66 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 177.6, 151.1, 131.9, 131.3, 128.7, 120.4, 116.7, 81.7, 60.3, 34.3, 26.0, 24.9 (1 peak overlapped).

[0098] <Example 5-2> In the presence of catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and isoxepac was halogenated. Specifically, 1 mole of the substrate Isoxepak was reacted with 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS in 1,2-dichloroethane solvent (substrate concentration 0.1M) at atmospheric pressure (1 atm) and room temperature for 18 hours to produce the compound represented by the following formula (yield 96%). [ka] 1 H NMR (400 MHz, CDCl3) δ 8.09 (d, J= 2.1 Hz, 1H), 7.99 (dd, J = 2.1, 7.7 Hz, 1H), 7.74 (d, J = 2.2 Hz, 1H), 7.60-7.56 (m, 1H), 7.51-7.46 (m, 1H), 7.39 (dd, J = 0.8, 7.5 Hz, 1H), 5.30 (s, 2H), 3.67 (s, 2H) (the OH peak not observed); 13 C NMR (100 MHz, CDCl3) δ 189.9, 156.9, 139.9, 139.7, 135.1, 133.1, 132.4, 129.6, 129.5, 127.94, 127.87, 126.5, 115.1, 74.2 (2 peaks overlapped); HRMS (EI) m / z: [M] + Calcd for C 16 H 11 79BrO4345.9841; Found 345.9833.

[0099] <Example 5-3> In the presence of Catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and aniracetam was halogenated. Specifically, 1 mole of the substrate aniracetam was reacted in the presence of 0.02 molar equivalents of catalyst F, 0.04 molar equivalents of AgSbF6 cocatalyst, and 2.0 molar equivalents of NBS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and 60°C for 18 hours to produce the compound represented by the following formula (yield 81%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.87 (d, J= 2.0 Hz, 1H), 7.62 (dd, J = 1.9, 8.6 Hz, 1H), 6.89 (d, J = 8.6 Hz, 1H), 3.95-3.91 (m, 5H), 2.62 (t, J = 7.7 Hz, 2H), 2.19-2.10 (m, 2H); 13 C NMR (100 MHz, CDCl3) δ 174.7, 168.7, 158.9, 134.8, 130.6, 127.4, 110.9, 110.5, 56.4, 46.8, 33.3, 17.7.

[0100] <Example 5-4> In the presence of catalyst F of Example 1-6, AgSbF6 promoter, and N-chlorosuccinimide (NCS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and ciprofibrate was halogenated. Specifically, 1 mole of the substrate ciprofibrate was reacted with 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NCS in 1,2-dichloroethane solvent (substrate concentration 0.2 M) at atmospheric pressure (1 atm) and room temperature for 18 hours to produce the compound represented by the following formula (yield 87%). [ka] 1 H NMR (400 MHz, CDCl3) δ 8.09 (very broad, 1H), 7.29 (d, J = 2.0 Hz, 1H), 7.09-7.03 (m, 2H), 2.83 (dd, J= 8.3, 10.6 Hz, 1H), 1.99 (dd, J = 7.5, 10.6 Hz, 1H), 1.79 (dd, J= 7.6, 8.2 Hz, 1H), 1.64 (s, 6H); 13 C NMR (100 MHz, CDCl3) δ 178.2, 150.1, 131.1, 130.8, 128.0, 121.0, 81.6, 60.3, 34.4, 26.0, 24.87, 24.86.

[0101] <Example 5-5> In the presence of catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-chlorosuccinimide (NCS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and leflunomide was halogenated. Specifically, 1 mole of the substrate leflunomide was reacted in the presence of 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 3.0 molar equivalents of NCS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and 60°C for 18 hours to produce the compound represented by the following formula (yield 88%). [ka] 1H NMR (400 MHz, CDCl3) δ 8.65 (d, J= 8.6 Hz, 1H), 8.51 (d, J = 0.5 Hz, 1H), 8.03 (s, 1H), 7.70 (d, J= 1.8 Hz, 1H), 7.59 (ddd, J = 0.5, 1.5, 8.7 Hz, 1H), 2.82 (d, J = 0.6 Hz, 3H); 13 C NMR (100 MHz, CDCl3) δ 173.4, 158.9, 147.7, 137.1, 127.0 (q, J = 33.5 Hz), 126.3 (q, J = 3.7 Hz), 125.2 (q, J = 3.7 Hz), 123.3 (q, J = 272.7 Hz), 122.6, 121.1, 112.0, 12.8; 19 F NMR (376 MHz, CDCl3) δ -62.4.

[0102] <Examples 5-6> In the presence of catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-chlorosuccinimide (NCS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and fenofibrate was halogenated. Specifically, 1 mole of the substrate fenofibrate was reacted with 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NCS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and room temperature for 18 hours to produce the compound represented by the following formula (yield 93%). [ka] 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J= 2.2 Hz, 1H), 7.70 (d, J = 8.6 Hz, 2H), 7.59 (dd, J = 2.2, 8.6 Hz, 1H), 7.47 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 1H), 5.10 (sept, J = 6.3 Hz, 1H), 1.69 (s, 6H), 1.23 (d, J = 6.3 Hz, 6H); 13 C NMR (100 MHz, CDCl3) δ 193.2, 172.7, 155.5, 138.8, 135.6, 132.4, 131.15, 131.13, 129.5, 128.7, 125.6, 116.9, 81.0, 69.5, 25.2, 21.5.

[0103] <Examples 5-7> In the presence of catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-iodosuccinimide (NIS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and nimesulide was halogenated. Specifically, 1 mole of the substrate nimesulide was reacted in the presence of 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NIS in 1,2-dichloroethane solvent (substrate concentration 0.2 M) at atmospheric pressure (1 atm) and 60°C for 18 hours to produce the compound represented by the following formula (yield 96%). [ka] 1H NMR (400 MHz, CDCl3) δ 6.69 (very broad, 1H), 7.68 (d, J = 2.1 Hz, 1H), 7.14 (dd, J = 1.9, 8.5 Hz, 1H), 6.89 (d, J = 8.5 Hz, 1H), 2.81 (dd, J = 8.4, 10.5 Hz, 1H), 1.97 (dd, J = 7.5, 10.4 Hz, 1H), 1.78 (t, J = 8.0 Hz, 1H), 1.69 (s, 6H); 13 C NMR (100 MHz, CDCl3) δ 178.8, 153.9, 134.0, 131.2, 129.7, 118.2, 91.4, 81.3, 60.4, 34.1, 26.0, 25.2.

[0104] <Example 5-8> In the presence of catalyst F of Example 1-6, AgSbF6 promoter, and N-iodosuccinimide (NIS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and ciprofibrate was halogenated. Specifically, 1 mole of the substrate ciprofibrate was reacted with 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NIS in 1,2-dichloroethane solvent (substrate concentration 0.2 M) at atmospheric pressure (1 atm) and room temperature for 18 hours to produce the compound represented by the following formula (yield 96%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.95-7.92 (m, 2H), 7.81-7.78 (m, 2H), 7.51-7.44 (m, 4H); 13 C NMR δ 167.6, 134.9, 134.0, 132.8, 132.5, 131.9, 124.2, 124.0.

[0105] <Example 5-9> In the presence of Catalyst F of Example 1-6, AgSbF6 promoter, and N-iodosuccinimide (NIS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and clofibrate was halogenated. Specifically, 1 mole of the substrate clofibrate was reacted with 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NIS in 1,2-dichloroethane solvent (substrate concentration 0.2 M) at atmospheric pressure (1 atm) and room temperature for 18 hours to produce the compound represented by the following formula (yield 98%). [ka] 1 H NMR (400 MHz, CDCl3) δ 6.69 (very broad, 1H), 7.68 (d, J = 2.1 Hz, 1H), 7.14 (dd, J = 1.9, 8.5 Hz, 1H), 6.89 (d, J = 8.5 Hz, 1H), 2.81 (dd, J = 8.4, 10.5 Hz, 1H), 1.97 (dd, J = 7.5, 10.4 Hz, 1H), 1.78 (t, J = 8.0 Hz, 1H), 1.69 (s, 6H); 13 C NMR (100 MHz, CDCl3) δ 178.8, 153.9, 134.0, 131.2, 129.7, 118.2, 91.4, 81.3, 60.4, 34.1, 26.0, 25.2; HRMS (EI) m / z: [M] + Calcd for C 13 H 13 35 Cl 37 ClO3I 415.9257; Found 415.9270.

[0106] <Examples 5-10> In the presence of Catalyst F of Example 1-6, AgSbF6 promoter, and N-iodosuccinimide (NIS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and flurbiprofen was halogenated. Specifically, 1 mole of the substrate flurbiprofen was reacted in the presence of 0.01 molar equivalent of catalyst F, 0.02 molar equivalent of AgSbF6 cocatalyst, and 1.0 molar equivalent of NIS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and 60°C for 18 hours to produce the compound represented by the following formula (yield 76%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.76 (d: A2portion of A2B2, J = 8.6 Hz, 2H), 7.36 (t, J= 8.0 Hz, 1H), 7.29-7.24 (m, 2H), 7.19-7.12 (m, 2H), 3.78 (q, J = 7.2 Hz, 1H), 1.55 (d, J = 7.2 Hz, 3H) (the OH peak not observed); 13 C NMR (100 MHz, CDCl3) δ 179.2, 159.5 (d, J = 248.7 Hz), 141.5 (d, J = 7.7 Hz), 137.6, 134.9, 130.7 (d, J = 3.0 Hz), 130.5 (d, J= 3.7 Hz), 127.1 (d, J = 13.1 Hz), 123.8 (d, J = 3.5 Hz), 115.5 (d, J = 23.6 Hz), 93.7, 44.7, 18.0; 19 F NMR (376 MHz, CDCl3) δ -117.1; HRMS (EI) m / z: [M] + Calcd for C 15 H 12 FO2I 369.9867; Found 369.9873.

[0107] [Example 6] <Example 6-1> In the presence of Catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and o-terphenyl was halogenated. Specifically, 1 mole of o-terphenyl substrate was reacted with 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 2.0 molar equivalents of NBS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and room temperature for 24 hours to produce the compound represented by the following formula (yield 81%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.45-7.36 (m, 8H), 7.00 (d, J = 8.6 Hz, 4H); 13 C NMR (100 MHz, CDCl3) δ 140.1, 139.2, 131.5, 131.3, 130.5, 128.0, 121.0.

[0108] <Example 6-2> In the presence of Catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and o-terphenyl was halogenated. Specifically, 1 mole of o-terphenyl substrate was reacted with 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 3.0 molar equivalents of NBS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and 60°C for 24 hours to produce the compound represented by the following formula (yield 76%). [ka] 1H NMR (400 MHz, CDCl3) δ 7.56-7.53 (m, 2H), 7.39-7.36 (m, 4H), 7.24 (dd, J = 0.7, 7.9 Hz, 1H), 6.98-6.94 (m, 4H); 13 C NMR (100 MHz, CDCl3) δ 141.1, 138.9, 138.7, 138.1, 133.2, 132.0, 131.45, 131.42, 131.3, 131.2, 131.0, 121.9, 121.6, 121.4.

[0109] <Example 6-3> In the presence of Catalyst F of Example 1-6, AgSbF6 cocatalyst, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and o-terphenyl was halogenated. Specifically, 1 mole of o-terphenyl substrate was reacted with 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 5.0 molar equivalents of NBS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and 60°C for 24 hours to produce the compound represented by the following formula (yield 80%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.63 (s, 2H), 7.38 (d, J = 8.6 Hz, 4H), 6.94 (d, J = 8.6 Hz, 4H); 13 C NMR (100 MHz, CDCl3) δ 139.8, 137.7, 135.1, 131.6, 131.1, 124.2, 121.9.

[0110] In recent years, research on nanocarbon materials, such as nanographene and carbon nanotubes, has been actively conducted, and it is expected that multihalogen compounds, which have multiple halogen substituents in the same molecule, will be useful building blocks for their production. However, the introduction of multiple halogen substituents at once generally requires harsh reaction conditions (e.g., using bromine or chlorine as a halogenating agent and heating at high temperatures with a strong acid), and chemical synthesis with controlled selectivity has been an extremely difficult task. In fact, the only reported examples of the bromination reaction of o-terphenyl that give a complex mixture have been reported [CFH Allen, FP Pingert, J. Am. Chem. Soc. 64, 11, 2639-2643 (1942).]. In contrast, as shown in the results of Examples 6-1 to 6-3, under the conditions in which the carborane catalyst according to the present invention was used, the amount of NBS used was adjusted to 2 to 5 equivalents relative to o-terphenyl, and thus the dibrominated, tribrominated, and tetrabrominated products could each be obtained in high yields. In addition, it is also possible to obtain previously undocumented multi-halogen compounds such as pentachlorophenanthrene and hexachlorochrysene in a single step from commercially available hydrocarbon molecules.

[0111] <Example 6-4> In the presence of catalyst F of Example 1-6, AgSbF6 promoter, and N-chlorosuccinimide (NCS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and tetraphenylmethane was halogenated. Specifically, 1 mole of the substrate tetraphenylmethane was reacted in the presence of 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 5.0 molar equivalents of NCS in 1,2-dichloroethane solvent (substrate concentration 0.2 M) at atmospheric pressure (1 atm) and 60°C for 24 hours to produce the compound represented by the following formula (yield 94%). [ka] 1H NMR (400 MHz, CDCl3) δ 7.24 (d, J= 8.8 Hz, 2H), 7.07 (d, J = 8.7 Hz, 2H); 13 C NMR (100 MHz, CDCl3) δ 144.1, 132.6, 132.0, 128.1, 63.3.

[0112] <Example 6-5> In the presence of catalyst F of Example 1-6, AgSbF6 promoter, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and tetraphenylmethane was halogenated. Specifically, 1 mole of the substrate tetraphenylmethane was reacted with 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 4.0 molar equivalents of NBS in 1,2-dichloroethane solvent (substrate concentration 0.2 M) at atmospheric pressure (1 atm) and room temperature for 24 hours to produce the compound represented by the following formula (yield 82%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.39 (d, J= 8.8 Hz, 8H), 7.01 (d, J = 8.8 Hz, 8H); 13 C NMR (100 MHz, CDCl3) δ 144.4, 132.4, 131.1, 120.8, 63.6.

[0113] <Example 6-6> In the presence of Catalyst F of Example 1-6, AgSbF6 promoter, and N-bromosuccinimide (NBS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and hexaphenylbenzene was halogenated. Specifically, 1 mole of the substrate hexaphenylbenzene was reacted in the presence of 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 1.0 molar equivalent of NBS in 1,2-dichloroethane solvent (substrate concentration 0.05M) at atmospheric pressure (1 atm) and 60°C for 24 hours to produce the compound represented by the following formula (yield 92%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.05 (d, J= 8.5 Hz, 12H), 6.61 (d, J = 8.5 Hz, 12H); 13 C NMR (100 MHz, CDCl3) δ 139.5, 138.4, 132.5, 130.4, 120.3.

[0114] <Examples 6-7> In the presence of Catalyst F of Example 1-6, AgSbF6 promoter, and N-chlorosuccinimide (NCS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and 2,6-dibromonaphthalene was halogenated. Specifically, 1 mole of the substrate 2,6-dibromonaphthalene was reacted in the presence of 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 4.0 molar equivalents of NCS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and 60°C for 24 hours to produce the compound represented by the following formula (yield 65%). [ka] 1 H NMR (400 MHz, CDCl3) δ 8.17 (d, J= 9.2 Hz, 1H), 7.89 (s, 1H), 7.83 (d, J = 9.2 Hz, 1H); 13 C NMR (100 MHz, CDCl3) δ 134.9, 133.4, 132.9, 131.7, 130.9, 129.9, 128.6, 126.9, 125.8, 121.0.

[0115] <Examples 6-8> In the presence of Catalyst F of Example 1-6, AgSbF6 promoter, and N-chlorosuccinimide (NCS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and 2,7-dibromonaphthalene was halogenated. Specifically, 1 mole of the substrate 2,7-dibromonaphthalene was reacted with 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 2.0 molar equivalents of NCS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and room temperature for 24 hours to produce the compound represented by the following formula (yield 74%). [ka] 1 H NMR (400 MHz, CDCl3) δ 7.72 (d, J= 8.8 Hz, 2H), 7.53 (d, J = 8.8 Hz, 2H); 13 C NMR (100 MHz, CDCl3) δ 134.4, 131.5, 130.3, 130.0, 128.6, 126.8.

[0116] <Examples 6-9> In the presence of catalyst F of Example 1-6, AgSbF6 promoter, and N-chlorosuccinimide (NCS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and phenanthrene was halogenated. Specifically, 1 mole of the substrate phenanthrene was reacted with 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 5.0 molar equivalents of NCS in 1,2-dichloroethane solvent (substrate concentration 0.05M) at atmospheric pressure (1 atm) and room temperature for 24 hours to produce the compound represented by the following formula (yield 49%). [ka] 1H NMR (400 MHz, CDCl3) δ 9.30 (dd, J= 1.1, 8.6 Hz, 1H), 7.73 (dd, J = 1.1, 7.8 Hz, 1H), 7.61 (d, J = 8.3 Hz, 1H), 7.54 (d, J = 8.3 Hz, 1H), 7.49 (dd, J = 7.8, 8.5 Hz, 1H); 13 C NMR (100 MHz, CDCl3) δ 132.8, 131.6, 131.5, 131.0, 130.7, 130.6, 130.5, 130.1, 130.0, 128.8, 127.5, 126.8, 125.6 (1 peak overlapped).

[0117] <Example 6-10> In the presence of catalyst F of Example 1-6, AgSbF6 promoter, and N-chlorosuccinimide (NCS) as a halogenating agent, a halosulfonium complex serving as a reactive species was generated in the system, and chrysene was halogenated. Specifically, 1 mole of the substrate chrysene was reacted in the presence of 0.025 molar equivalents of catalyst F, 0.05 molar equivalents of AgSbF6 cocatalyst, and 6.0 molar equivalents of NCS in 1,2-dichloroethane solvent (substrate concentration 0.1 M) at atmospheric pressure (1 atm) and room temperature for 48 hours to produce the compound represented by the following formula (yield 19%). [ka] 1 H NMR (400 MHz, CDCl3) δ 8.86 (dd, J = 1.2, 8.5 Hz, 2H), 7.75 (dd, J= 1.2, 7.8 Hz, 2H), 7.50 (dd, J = 7.8, 8.5 Hz, 2H); 13 C NMR (100 MHz, CDCl3) δ 132.6, 131.3, 131.0, 129.75, 129.73, 129.4, 127.4, 126.7, 126.5. [Industrial Applicability]

[0118] As described above, the carborane catalyst according to the present invention has superior reaction activity and high selectivity compared to the prior art, and its revolutionary effect in this field has been fully recognized. The dramatic improvement in efficiency of chemical synthesis processes, which have previously been considered difficult, as well as the ability to create a wide variety of new building blocks, are expected to have a major ripple effect both academically and industrially.

Claims

1. A carborane compound represented by the following general formula (1): 【Chemistry 1】 (In the formula, R 1 , and R 2 each independently represents a hydrogen atom or a sulfur atom-containing substituent; R 1 and R 2 At least one of these is a sulfur atom-containing substituent.

2. 2. The carborane compound of claim 1, wherein the sulfur atom-containing substituent is an alkylthio group.

3. R 1 , and R 2 The carborane compound according to claim 1 , wherein is an alkylthio group.

4. The carborane compound according to claim 1 or 2, wherein the boron atom constituting the carborane compound further has a substituent.

5. 5. The carborane compound according to claim 4, wherein the substituent is selected from the group consisting of an acyl group, a siloxy group, a silyl group, an alkyl group, and a halogen atom.

6. 5. The carborane compound of claim 4, wherein said substituents are not present on the 2- and 3-position boron atoms.

7. 3. A method for producing a halogenated aromatic compound, comprising reacting an aromatic compound having at least one aromatic group, the aromatic group having at least one hydrogen atom, in the presence of the carborane compound according to claim 1 or 2, a co-catalyst, and a halogenating agent to obtain a halogenated aromatic compound, the aromatic group having a halogen atom.

8. The method for producing a halogenated aromatic compound according to claim 7, wherein the reaction is carried out in the presence of an aprotic solvent.

9. 8. The method for producing a halogenated aromatic compound according to claim 7, wherein the co-catalyst is at least one selected from the group consisting of indium(III) trifluoromethanesulfonate, trifluoromethanesulfonic acid, silver trifluoromethanesulfonate, silver(I) tetrafluoroborate, silver(I) hexafluorophosphate, and silver hexafluoroantimonate(V).

10. 8. The method for producing a halogenated aromatic compound according to claim 7, wherein the co-catalyst is silver hexafluoroantimonate (V).

11. The method for producing a halogenated aromatic compound according to claim 7, wherein the halogenating agent is an N-halogen atom bond type halogenating agent.

12. The method for producing a halogenated aromatic compound according to claim 7, wherein the reaction temperature is within the range of 5 to 100°C.

13. 8. The method for producing a halogenated aromatic compound according to claim 7, wherein the halogen atom is selected from the group consisting of a chlorine atom, a bromine atom, and an iodine atom.

14. Halogenated aromatic compounds represented by the following formulas (3-1) to (3-6). 【Chemistry 2】 【Chemistry 3】 【Chemistry 4】 【Chemistry 5】 【Chemistry 6】 or 【Chemistry 7】

Citation Information

Patent Citations

  • Preparation of aryl halide

    JP1980047633A

  • Method for producing halogenated aromatic compound

    WO2008143141A1